USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ZETRA BIOLOGICALS, LLC
Address:
ZETRA BIOLOGICALS, LLC
3961 WOBURN DR
TUCKER, GA
Phone:
N/A
URL:
N/A
EIN:
120821936
DUNS:
791285062
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,799,996.00 3

Award List:

Enhancement of mucosal antibody responses to HIV vaccine

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$600,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Since 1981, when HIV was first recognized as a serious and deadly disease, the number of infected people has risen to nearly 60 million. There are approximately 14,000 new HIV infections per day, and the WHO predicts th at HIV poses the greatest threat to global… More

Adjuvant-containing chimeric virus-like particles as improved influenza vaccines

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$599,998.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Although the influenza vaccine has been used for over 60 years, the current vaccination strategy against influenza A and B viruses is vulnerable to the unanticipated emergence of epidemic strains that are poorly matche d by the vaccine. Epidemics of seasonal… More

Virus-like particle vaccines against respiratory syncytial virus

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$599,998.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Our long term goal is to develop a safe, effective vaccine to prevent respiratory syncytial virus (RSV) disease. RSV is the leading cause of bronchiolitis, viral pneumonia, respiratory failure, and mechanical ventilatio n in infants. It causes gt120,000 infant… More